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Introduction
Osteoradionecrosis (ORN) is one of the complications
after high-dose-radiotherapy due to damage to normal
bony tissues. ORN may occur years after radiotherapy
and clinical manifestation may mimic disease recurrence.
This study aimed to determine the incidence of ORN
shown in 18F-FDG-PET-CT of post-radiotherapy head
and neck cancer (HNC) patients.
Methods
Retrospective analysis of 386 PET-CT scans of post-
radiotherapy HNC was performed. Total dose of radio-
therapy, time duration after radiotherapy and SUVmax
were recorded. Final diagnosis was reached by biopsy,
clinical and imaging follow-up.
Results
Out of 386 scans, 41 cases demonstrated abnormal
increased bony/cartilaginous uptake. Of which 22 were
confirmed as residual local osseous involvement of pre-
existing bony disease, 8 due to disease recurrence at
new sites of bone/cartilage, 7 due to benign causes such
as dental infection, and 4 due to ORN with no previous
local osseous involvement. The incidence of ORN is
1.0% (4/136) of total PET-CT scans and 9.8% (4/41) of
increased osseous FDG-uptake. Average occurrence of
ORN was 6 months after radiotherapy (range 2 months
to 3 years), all received over 60 Gray of radiation dose.
Mean-SUVmax of ORN was 6.6, not significantly differ-
ent from disease recurrence (mean-SUVmax=8.2,
P=0.23).
Conclusion
ORN is a rare complication after high-dose radiotherapy
seen in PET-CT (1.0%), but when abnormal increased oss-
eous FDG-uptake is seen within the previous radiotherapy
field then ORN should be considered as a differential
diagnosis (9.8% of increased osseous uptake). ORN may
occur years after treatment and symptoms mimic disease
recurrence. There is no significant difference in SUVmax
values between ORN and recurrence.
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